Literature DB >> 9194740

Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture.

J A Shields1, C L Shields, P De Potter.   

Abstract

To our knowledge, there are no articles that describe the specific step-by-step details of the surgical removal of premalignant and malignant conjunctival tumors. We describe our current approach to the surgical management of squamous cell carcinoma (intraepithelial or invasive), localized melanoma, and primary acquired melanosis of the conjunctiva. The surgical method differs with limbal tumors, extralimbal tumors, and primary acquired melanosis. Limbal lesions are managed by localized alcohol corneal epitheliectomy, removal of the main mass by a partial lamellar scleroconjunctivectomy, and supplemental cryotherapy. Tumors located in the extralimbal conjunctiva are managed by alcohol application, wide circumferential surgical resection, and cryotherapy. Primary acquired melanosis is managed by alcohol epitheliectomy, removal of suspicious foci, quadrantic staging biopsies, and cryotherapy from the underside of the conjunctiva. In all cases, a "no touch" method is used and direct manipulation of the tumor is avoided to prevent tumor cell seeding into a new area. We have employed this technique on 109 patients with conjunctival squamous neoplasms and 137 patients with conjunctival melanoma, about 80 of which neoplasms were associated with primary acquired melanosis. Our observations suggest that well-planned initial surgical management using this technique decreases the chance of tumor recurrence for conjunctival melanoma and squamous cell carcinoma. We describe a detailed stepwise approach to the surgical management of conjunctival neoplasms. It requires meticulous clinical evaluation and complete removal of the tumor in one operation using a specific technique.

Entities:  

Mesh:

Year:  1997        PMID: 9194740     DOI: 10.1001/archopht.1997.01100150810025

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  75 in total

1.  Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C.

Authors:  Carol L Shields; Hakan Demirci; Jerry A Shields; Christopher Spanich
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Conjunctival melanoma.

Authors:  Carol L Shields
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.

Authors:  Christina S Moon; Afshan A Nanji; Anat Galor; Kathryn E McCollister; Carol L Karp
Journal:  Ophthalmology       Date:  2015-12-11       Impact factor: 12.079

4.  Fresh frozen amniotic membrane for conjunctival reconstruction after excision of neoplastic and presumed neoplastic conjunctival lesions.

Authors:  U Agraval; P Rundle; I G Rennie; S Salvi
Journal:  Eye (Lond)       Date:  2017-02-17       Impact factor: 3.775

5.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 6.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

Review 7.  Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma.

Authors:  Joel M Mor; Ludwig M Heindl
Journal:  Ocul Oncol Pathol       Date:  2016-12-08

8.  Epiphora as a side effect of topical mitomycin C.

Authors:  E Dafgård Kopp; S Seregard
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

9.  Blue Nevi of the Ocular Surface: Clinical Characteristics, Pathologic Features, and Clinical Course.

Authors:  Ibrahim Sayed-Ahmed; Juan Carlos Murillo; Pedro Monsalve; Jan Paul Ulloa; Maria P Fernandez; James Wong; George Elgart; Anat Galor; Sander R Dubovy; Carol L Karp
Journal:  Ophthalmology       Date:  2018-03-15       Impact factor: 12.079

10.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.